Synopsis of recent research by authors named "Jinxin Li"
- Jinxin Li's recent research primarily focuses on innovative cancer therapies, drug repositioning via heterogeneous networks fusion, and improving diagnostic methods for complex diseases, such as renal cell carcinoma and bone metastasis.
- Significant findings include the role of colony-stimulating factor in bone metastasis, the impact of NDR1 in immune escape for prostate cancer, and the potential of CT radiomics-based biomarkers for predicting hepatocellular carcinoma response to immunotherapy.
- Li's work also expands to therapeutic advancements in ophthalmology and explores novel drug delivery mechanisms for leukemia, underscoring a commitment to bridging computational methods with clinical applications in cancer treatment and diagnostics.